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Abstract
The Tsimane of lowland Bolivia are an indigenous forager-farmer population living under
conditions resembling pre-industrial European populations, with high infectious morbidity, high
infection and inflammation, and shortened life expectancy. Analysis of 917 persons ages 5 to 60+
showed that allele frequencies of 9 SNPs examined in the apolipoprotein E (apoE), C-reactive
protein (CRP), and interleukin-6 (IL-6) genes differed from some European, African, and north
Asian-derived populations. The apoE2 allele was absent, whereas four SNPs related to CRP and
IL-6 were monomorphic: CRP (rs1800947, rs3093061, and rs3093062) and IL-6 (rs1800795). No
significant differences in apoE, CRP, and IL-6 variants across age were found CRP levels were
higher in carriers of two CRP proinflammatory SNPs, whereas they were lower in carriers of
apoE4. Taken together, the evidence for (1) different allele frequencies between the Tsimane and
other populations and (2) the correlations of CRP and apoE alleles with blood CRP may suggest
that these variants are under selection in response to a high infection environment.
Introduction
This study analyzes the distribution of genetic diversity in a set of single nucleotide
polymorphisms (SNPs) in the Tsimane of Bolivia, a population of hunter-forager-farmers
with a high infectious burden and shortened lifespan (Gurven, Kaplan, and Supa 2007;
Gurven, Kaplan, Winking, Finch, and Crimmins 2008; McDade et al. 2005; Vasunilashorn
et al. 2010). Genetic variation within and between populations may be associated with a
variety of factors (Drenos and Kirkwood 2010; Finch and Stanford 2004), including natural
selection in resistance to pathogens (Pennington et al. 2009). A classic example is malaria,
in which individuals who are heterozygous for the β-globin sickle-cell allele are more
resistant to malaria and thus have a survival advantage (Flint, Harding, Boyce, and Clegg
1998; López et al. 2010; Wellems, Kayton, and Fairhurst 2009). Other chronic infections
may influence the frequencies of genetic variants at different ages within a population
through selective advantage from innate immune responses (Drenos, Westendorp, and
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Kirkwood 2006; Harpending and Cochran 2006; Kuningas et al. 2009). The advent of high
throughput DNA technology, along with the growing characterization of genes, has made it
possible to determine genetic dispositions to disease (Collins, Guyer, and Charkravarti 1997;
Hardy and Singleton 2009) and to determine the associations between genetic variation and
human traits (Goldstein 2009; Huang et al. 2007; Khor et al. 2010; Yashin et al. 2000). The
present study applies this technology to three gene-encoding blood proteins that were chosen
because of their influence on inflammatory responses and lifespan including apolipoprotein
E (apoE), C-reactive protein (CRP), and interleukin-6 (IL-6).
Significance
The population genetics of indigenous South American populations has received less
attention than the genetics of Eurasian and African populations. The Amazonian Tsimane
are of particular interest because of detailed information on their demographics, infectious
load, and high level of inflammation. Until recently, the Tsimane have had little access to
modern medicine, which has led to low levels of life expectancy. Thus, it may be possible to
define signatures of natural selection in gene variants with functional influences across life
history. With respect to our results, the different SNP frequencies observed between the
Tsimane and other populations as well as the correlations of CRP and apoE alleles with
blood CRP levels suggest that these genes (and other inflammatory proteins) may be under
genetic selection in response to a highly infectious environment. By addressing questions
that are relevant to genetics research in this indigenous population, our study may have
broad and important implications for the field of social sciences. Such a study contributes to
our understanding of the record of human history and more broadly is relevant to a wider
range of disciplines as it deals with the amount of variation in health and aging that is a
result of social or selective environmental pressures.
Background
Genetic Markers Associated with Infection and Inflammation
This study analyzes allele frequencies of selected immune response genes in the Tsimane of
Bolivia, a population exposed to a very high infectious burden with elevations of serum CRP
levels, parasite infection, and white blood cell count (Gurven et al. 2007 2008; McDade et
al. 2005; Vasunilashorn et al. 2010). In this study, we examine variants of genes encoding
apoE, CRP, and IL-6. Differences in allele frequencies among populations may provide
some insight as to the interaction between genes and the environment and the relevance of
natural selection in shaping variation in immune-related genes both within and among
populations. We also examined genotype frequencies across various age ranges to evaluate
possible genetically related survival advantages to living under conditions of infectious
environment. Some of the genes that enhance survival from infection by increased
inflammatory responses may also promote aging among survivors later in life through their
effects on inflammatory mechanisms in chronic conditions of aging (Franceschi et al. 2000,
2005; Finch 2007). Finally, we investigate the relationship between serum markers of
infection and inflammation on proinflammatory genotypes among the Tsimane. We
hypothesize that there will be a positive association between proinflammatory genotypes and
blood markers of inflammation.
C-reactive Protein—CRP, an acute-phase response protein, is a marker of systemic
inflammation, and its expression is influenced by genetic factors, infection, trauma, and the
presence of chronic conditions (Ridker et al. 2008, 2009). Heritability estimates for serum
CRP levels in various populations range from 27 to 40 per cent (Dupuis et al. 2005; Pankow
et al. 2001), suggesting the influence of genetic factors. In agreement with this notion,
several SNPs and haplotypes at the CRP locus have been associated with blood CRP levels
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(Crawford et al. 2006; Eirksdottir et al. 2009; Kathiresan et al. 2006; Ridker et al. 2008;
Szalai et al. 2005; Teng et al. 2009) including those that are located in introns (Szalai 2002),
exons (Zee and Ridker 2002), the upstream promoter (Brull et al. 2003; Kovacs et al. 2005),
and the 3′-untranslated regions of the mRNA (Brull et al. 2003). Genetic markers related to
CRP production have also been associated with survival from infection as well as with
serum levels of other inflammatory markers related to the immune response (Balding et al.
2003; Slattery et al. 2007; Walston et al. 2005).
Interleukin-6—IL-6 is another protein involved in the acute-phase inflammatory response
that has broad metabolic roles in normal metabolism and is controlled by genetic variation.
For example, a G>C substitution (rs1800795) at position –174 of the IL-6 promoter has been
associated with resistance to infection and enhanced survival during bacterial meningitis
(Balding et al. 2003). Importantly, this variant has also been associated with serum IL-6
levels (de Craen et al. 2005; Slattery et al. 2007; Walston et al. 2005).
Apolipoprotein E—ApoE has three common alleles with the order of prevalence being
apoE3 > apoE4 > apoE2 in most populations. The apoE4 allele is a common genetic risk
factor for cardiovascular disease and Alzheimer’s disease (Corder et al. 1996; Eichner et al.
2002; Huang 2006; Lahoz et al. 2001; Rosvall et al. 2009; Wilson et al. 1996) and reduces
life expectancy by about 5 years in European-derived populations (Ewbank 2004, 2007;
Schachter et al. 1994; Smith 2002). However, apoE4 may also influence infectious
conditions, as indicated by other reports. For example, in hepatitis C virus infections, apoE4
carriers developed less severe liver fibrosis (Fabris et al. 2005; Wozniak et al. 2002). In
addition, children in a Brazilian favela with at least one apoE4 allele had less Giardia and
fewer bouts of diarrhea than those with other apoE alleles (Oriá et al. 2010).
The apoE4 allele influences inflammatory responses and, relative to apoE3, is
proinflammatory in some conditions. Among humans after surgery, apoE4 carriers exhibited
higher levels of tumor necrosis factor (TNF)-α compared to apoE3/E3 patients (Drabe et al.
2001; Grunenfelder et al. 2004; Olgiati et al. 2010). A mouse model supports these allele
effects. For example, brain monocytes (microglia) from transgenic mice expressing apoE4
secreted more TNFα, IL-6, and nitric oxide than mice with the apoE3 allele (Vitek, Brown,
and Colton 2009).
The apoE allele frequencies vary widely between human populations of Europe, Africa,
Australia, and North America (Corbo and Seacchi 1999; Finch 2007; Singh, Singh, and
Mastana 2006). ApoE2 is the least prevalent (Sakuma et al. 1995) whereas apoE3 is the
most prevalent, with >50% frequency in all human populations studied. ApoE4 shows more
variation with prevalence varying from 49 per cent among the Huli of New Guinea to absent
among the Ache in Paraguay (Demarchi et al. 2005). Geographic distributions indicate that
Northern Europe has a greater apoE4 prevalence than Mediterranean regions (Corbo and
Scacchi 1999; Demarchi et al. 2005; Gerdes, Klausen, Sihm, and Faergeman 1992; Panza et
al. 2003). Less economically developed and traditional pre-industrial societies also vary
widely in apoE alleles: apoE2 is absent in the East Greenland Inuit (Gerdes et al. 1996);
Mayans of Mexico (Kamboh, Weiss, and Ferrell 1991); Yanomamo of Brazil (Crews,
Kamboh, Mancilha-Carvalho, and Kottke 1993); Australian aborigines (Kamboh,
Serjeantson, and Ferrell 1991), Hichol Indians from western Mexico (Aceves et al. 2006);
and Amerindians from nine different tribes in Central and South America (Asakawa,
Takahashi, and Rosenblum 1985). Conversely, apoE4 is relatively frequent in the East
Greenland Inuit (Gerdes et al. 1996); Saami of Finland (Lehtinen et al. 1994); Nigerians
(Sepehrnia et al. 1988; Kamboh et al. 1989; Sandholzer, Delport, Vermaal, and Utermann
1995); and aborigines from Australia (Kamboh, Serjeantson, and Ferrell 1991a), Papua New
Guinea (Kamboh, Bahtia, and Ferrell 1990), and Malaysia (Gajra et al. 1994). These wide
VASUNILASHORN et al. Page 3
Biodemography Soc Biol. Author manuscript; available in PMC 2012 December 24.
$watermark-text
$watermark-text
$watermark-text
distributions in allele frequencies suggest the influence of founder effects and/or potential
selective influences on survival via proinflammatory responses in environments with
variable pathogenicity.
Mortality and Infection in the Tsimane
Our analysis focuses on the Tsimane, who live in a highly infectious environment. These
indigenous forager-farmers in lowland Amazonian Bolivia live under conditions similar to
pre-industrial European populations with high infectious morbidity, limited diets, and short
life expectancy (Gurven et al. 2007 2008; McDade et al. 2005). Extensive demographic data
document the level of mortality in two periods: 1950–1989 and 1990–2000 (Gurven et al.
2007). Life tables indicate short life expectancy at birth relative to the standards of
contemporary developed countries: 44.2 years for males and 42.8 years for females before
1990 and 54.3 for males and 54.0 for females during the 1990–2000 period. Survival curves
from life tables for these two periods (Figure 1) show the marked recent improvements in
survival. For example, between 1950 and 1989, 20 per cent of the Tsimane (21 per cent of
females and 19 per cent of males) died before their fifth birthday; this high early mortality
decreased by about 25 per cent during the next decade, 1990–2000. By age 35 in the earlier
period (the midpoint of the 10- to 59-year range), the proportion dying was about 37 per cent
(39 per cent for women and 34 per cent for men). From 1990 to 2000, this proportion
decreased to 25 per cent. During the period 1950 to 1989, 60 per cent of the cohort died
before age 60 (61 per cent for females; 59 per cent for males), which was reduced to 40 per
cent during the later period. Despite these improvements, the major cause of death at all ages
is infectious disease. Among children, respiratory and gastrointestinal conditions are the
primary causes of death but, among people beyond age 60, deaths are due to respiratory
conditions, including tuberculosis (Gurven et al. 2007). A higher life expectancy for males
than females has been observed in other populations with low life expectancy, including
Afghanistan (males [M] 46.62, females [F] 45.10 years), Bangladesh (M 60.40, F 59.91),
Niger (M 41.43, F 41.11), and Zimbabwe (M 39.18, 36.34) in 2000. In these societies, not
only is life expectancy relatively low but fertility is still high, and maternal mortality is an
important cause of the low life expectancy of women.
The Tsimane are exposed to high levels of inflammation, infection, and parasitic load
(Gurven et al. 2008; McDade et al. 2007; Tanner et al. 2009; Vasunilashorn et al. 2010).
About 40 per cent have elevated levels of CRP (≥ 3 mg/l), and 60 per cent had high IL-6
(≥2.68 pg/ml). The total white blood cell count averaged 10,344 cells/mm3, which is in the
upper normal range of clinical samples from the United States (Table 1). In contrast, mean
white blood cell count for individuals in the United States without coronary heart disease is
7,500 cells/mm3 (Friedman et al. 1974). At any given time, the majority (nearly 75 per cent)
of subjects had at least one parasite; two or more parasites were carried by 40 per cent of
individuals sampled in 2004, and the average number of parasite species per person was 1.3
(Vasunilashorn et al. 2010). The most prevalent parasites include a hookworm (46 per cent),
protozoa (Entamoeba coli, 22 per cent, and Iodamoeba butschilii, 17 per cent), and
roundworm (Ascaris lumbricoides, 17 per cent). During medical exams, more than 60 per
cent had symptoms of respiratory or gastrointestinal illness (Gurven et al. 2008). Malaria
and HIV have not been reported among the Tsimane through 2010.
To investigate the relationship between living in a high infection environment and allele and
genotype frequencies associated with inflammation, we used blood samples collected from
the Tsimane. As blood was not collected from children younger than age 5, the present study
examined the distribution of the genetic markers in three age groups: 5 to 9, 10 to 59, and
60+. We assume that the children currently between the ages of 5 and 9 have lived under the
more recent mortality levels and that about 90 per cent of the original birth cohort has
survived. At the older ages, the proportion of subjects alive most likely reflects a
VASUNILASHORN et al. Page 4
Biodemography Soc Biol. Author manuscript; available in PMC 2012 December 24.
$watermark-text
$watermark-text
$watermark-text
combination of the mortality schedules from the earlier and the later periods. We estimate
that about 30 per cent of the original cohort, who would now be 35-year-olds, have died and
that about 55 per cent of those who were in the original cohort of those 60 years of age or
older are deceased.
In the present study, we first compared the allelic frequencies of loci associated with
inflammation and survival in the Tsimane to other populations to provide insight as to the
relationship between genetic variation and environment. Second, we examined genotype
frequencies with age to evaluate possible survival advantages under conditions including
significant infectious exposure. Last, we investigated the relationship between genotype and
serum levels of CRP.
Methods
Clinical Measurements
Blood was separated and spun in the field and frozen in liquid nitrogen for transport to the
University of New Mexico where it was assayed for serum CRP levels. Frozen lymphocytes
were sent to the University of Southern California for DNA extraction and genotyping.
Serum high sensitivity-CRP and IL-6 were measured using assays with detectable ranges of
0.1 to 150.0 mg/L and 2.0 to 1,000.0 pg/mL, respectively, at the Tricore Reference
Laboratories in Albuquerque using Immulite 2000 kits. The mean replicate interassay
coefficient of variation was 5.6 per cent for hs-CRP and 5.8 per cent for IL-6 (Diagnostics
Products Corporation, Siemens, Deerfield, IL, USA). White blood cell count was analyzed
in the field using fresh samples.
Molecular Analysis
Single nucleotide polymorphism (SNP) genotyping was performed using the Applied
Biosystems TaqMan system (Livak 2003). Briefly, for each SNP, a polymerase chain
reaction containing 2 ng of genomic DNA, amplification primers, and two 20–30-bp
oligonucleotides encompassing the polymorphic site were carried out according to
manufacturer’s protocols. Genotyping assays were selected through Applied Biosystems
“Assays on Demand” database (http://myscience.appliedbiosystems.com/%20navigation/
http://myscience.appliedbiosystems.com/navigation/mysciapplications.jsp) or custom-
designed using the “Assays by Design” service. Primer and probe sequences can be
provided upon request.
Genetic loci examined in this study were chosen based on previously reported associations
with blood levels of CRP or IL-6 (Table 2). These included 7 SNPs in the CRP gene
(Carlson et al. 2005) and a promoter SNP in IL-6. Determination of the apolipoprotein E2/
E3/E4 alleles used genotypes derived from two SNPs, rs429358 and rs7412, as reported
previously (Nyholt, Yu, and Visscher 2009).
To investigate how genotypes vary with age, we examined genotypes for specific SNPs
associated with the highest blood CRP and IL-6 levels based on published studies. These
genotypes are listed as “proinflammatory genotypes” in Table 3. For genetic variants
associated with apoE, the proinflammatory genotype was designated by the genotype
associated with the greatest risk for adverse conditions or outcomes in old age. The
proinflammatory genotypes for the SNPs examined in the current study are apoE4/E4 and
rs405509_GG for apoE (Mahley 1988; Mahley and Rall 2000; Schachter et al. 1994; Song,
Stampfer, and Liu 2004); rs1205_GG, rs1417938_TT, rs1800947_GG, rs3093061_AA,
rs3093062_GG, rs2808630_AA, rs3091244_AA for CRP (Crawford et al. 2006; Eiriksdottir
et al. 2009; Teng et al. 2009; Szalai et al. 2005; Kathiresan et al. 2006; Ridker et al. 2008);
and rs1800795_GG for IL-6 (Bamouldi et al. 2006; Walston et al. 2005).
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All protocols were approved by the institutional review boards at the University of New
Mexico, the University of Southern California, and the University of California, Santa
Barbara.
Comparison Populations
We also compared allele frequencies in the Tsimane with various other populations,
including Africans, Asians, Caucasians, and Hispanics, using the available data from the
HapMap project.
Statistical Analyses
Differences in genotype prevalence as a function of age were determined using chi-squared
tests. Ordinary least squares regression was used to determine the associations between
proinflammatory genotypes and blood CRP levels. Model I was adjusted for age and gender.
Model II additionally adjusted for body mass index, as adiposity can influence CRP levels
(Visser et al. 1999; Wee et al. 2008). Given the non-linear distribution of CRP in the
population, CRP was log-transformed in multivariate analyses. All analyses were carried out
with SAS 9.1 (SAS Institute, Inc., Cary, NC, USA), and p-values less than 0.05 were
considered significant.
Results
Allele Frequencies of CRP SNPs in the Tsimane and Other Populations
The allele frequencies of the selected SNPs in the CRP gene for the Tsimane and other
populations are summarized in Table 3. Though the frequencies of SNPs rs1800947,
rs3093061, rs3093062, and rs1205 were comparable between the Tsimane and other
populations, there were also some notable differences. For example, the A allele of
rs1417938 was present in 62 per cent of the Tsimane and 47 per cent of Caucasians but in
less than 5 per cent of Asians and Africans. In addition, the A allele of the tri-allelic SNP
rs3091244 was twice as frequent in the Tsimane compared to Caucasians and was
completely absent in Africans, whereas rs2808630 was least frequent in the Tsimane (see
Table 3).
Proinflammatory Genotypes
Of three SNPs in the CRP gene and one in the IL-6 gene, only the genotypes considered to
be proinflammatory were present in the Tsimane (rs1800947_GG, rs3093062_GG, and
rs3093061_AA, and rs1800795_GG). In addition, the AA genotype of the tri-allelic SNP
rs3091244 was present at 38 per cent.
The apoE4/E4 proinflammatory genotype was present in 2.9 per cent of the Tsimane sample
whereas the at-risk genotype (GG) of the SNP in the promoter region (rs405509), which has
also been associated with Alzheimer’s disease (Bizzarro et al. 2009), was found in 6.4 per
cent of the Tsimane (see Table 3).
Distributions of Genotypes by Age
Based on the allele frequency variations observed in the Tsimane, we examined the age
distribution of proinflammatory genotypes at several loci. These included the apoE4 allele,
apoE rs405509, and CRP SNPs rs1417938_TT, rs3091244_AA, rs1205_GG, and
rs2808630_AA, which have been associated with serum CRP levels. We did not examine
the age distribution for CRP SNPs rs1800947 and rs3093062 and IL-6 SNP rs1800795, as
the Tsimane were monomorphic at these loci. ApoE allele frequencies by age group are
shown in Table 4. ApoE2 was absent from the sample, and E3/E3 was the most prevalent for
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all age groups (range: 68 to 76 per cent), followed by E3/E4 (range: 21 to 27 per cent). E4/
E4 was the least prevalent (range: 0 to 5 per cent), and there was a slightly higher proportion
of E4/E4 at ages 60+ compared to earlier ages. There was a non-significant positive trend
between age and the frequency of E4/E4 (r = 0.05, p = 0.13). CRP genotypes showed
divergent trends with age (see Table 4), with rs3091244_AA exhibiting the strongest
association with age: 42.0 per cent among ages 5 to 9, 42.8 per cent among ages 10 to 59,
and 30.3 per cent among adults age 60+; p < 0.03). For the other genotypes at rs3091244,
less age group variation was observed, with the range of frequencies by age being 0 to 1.7
per cent for rs3091244_CT; 16.0 to 19.3 per cent for CC; 0 to 2.5 per cent for AT; and 39.6
to 48.7 per cent for AC. These preliminary findings do not support the hypothesis that
proinflammatory CRP genotypes favor survival to later ages.
Blood CRP and Genotypes
We next determined whether serum CRP levels differed as a function of genotype. Subjects
homozygous for the apoE3 allele had significantly higher CRP levels compared to apoE3/E4
and apoE4/E4 subjects (Figure 2; Table 5). By comparison, there was no relationship
between proinflammatory genotypes of apoE SNP rs405509 and CRP SNPs rs1417938,
rs3091244, and rs2808630 and blood CRP levels (p = 0.81, p = 0.48, p = 0.21, and p = 0.44,
respectively; see Table 5). Adjusting for body mass index did not attenuate the relationship
between the apoE4 allele and blood CRP levels or alter the results with the other four SNPs.
The proinflammatory genotype of CRP rs1205 was associated with higher levels of blood
CRP (p = 0.04, Model I) but was no longer significant after adjusting for body mass index.
Discussion
This preliminary study of genetic markers in the Tsimane suggests some notable differences
in allele frequencies relative to other populations. For example, the apoE2 allele is absent in
this relatively large sample of Tsimane subjects, which is consistent with studies of five
Brazilian Amazonian tribes (Yanomami, Wayan-Apalai, Wayampi, Arara, Kayapo;
Asakawa et al. 1985; Crews et al. 1993; Marin et al. 1997); Mayans of Mexico (Kamboh,
Weiss, and Ferrell 1991b); and Australian aborigines (Kamboh et al. 1991a). The absence of
the E2 allele in the Tsimane and these other populations may be due to selection or genetic
drift. However, based on our results, we cannot distinguish between these possibilities. It is
also possible that apoE2 is very rare in the Tsimane, which precluded its detection in the
number of samples we analyzed in this study. It is interesting to note that in European-
derived populations, apoE2 is associated with higher triglyceride levels (Genest 2003;
Eichner et al. 2002), which is a metabolic phenotypes not exhibited by the Tsimane.
In addition, we did not find support for our hypothesis that proinflammatory alleles of apoE
and CRP would favor survival to later ages, although the apoE4 allele was observed at
slightly, but not significantly, higher frequency in older Tsimane. With a larger sample, this
difference could be significant, which could indicate that, under the environmental
conditions in which the Tsimane live, subjects carrying apoE4 have greater survival to older
age (Finch 2007; Finch and Morgan 2007). Such an observation would be opposite to trends
for lower survival of E4 carriers at older ages in United States and European populations
where infection levels are lower (Ewbank 2004; Gerdes et al. 2000; Rontu et al. 2006).
The different genotype distribution with age for rs3091244 (CRP) suggests an age difference
in the distribution of the AA proinflammatory genotype, but additional studies will be
required to confirm this relationship. We also observed an association of the apoE4 allele
with CRP in the Tsimane, where apoE3/E4 and apoE4/E4 carriers had lower levels
compared to apoE3/E3 subjects (see Figure 2); the correlation remained significant after
adjustment for body mass index. Similar associations with apoE4 have been reported in
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Finnish nonagenarians (Rontu et al. 2006), U.S. Latinos, and Japanese-Americans (Aiello,
Nguyen, and Haan 2008; Austin et al. 2004). These associations could arise from various
mechanisms, including differential binding of apoE4 to very-low-density lipoprotein
cholesterol (Austin et al. 2004) and hepatic clearance of CRP with involvement of the
mevalonate pathway (Rontu et al. 2006).
We note some limitations of our study. For example, infants and children younger than than
age 5 were not included in our analysis but will be included in future studies. In addition,
CRP levels based on a single sampling may not accurately represent relationships between
genetic variants and inflammatory phenotypes, as CRP levels can vary substantially during
infection and are influenced by other genes, such as interleukin (IL)-1, and IL-6. We also
acknowledge that the observed allelic associations (or lack thereof) need to be validated with
additional samples to draw any firm conclusions. Moreover, examining individual SNPs and
their associations with a given phenotype must be interpreted cautiously due to linkage
disequilibrium with other variants, which can vary across genomic regions and have not
been determined in an isolated and unique population such as the Tsimane. Thus, carrying
out dense SNP genotyping across loci of interest (e.g., IL-6 or IL-1) in conjunction with
quantitating additional biomarkers/cytokines may help to provide a better understanding of
the complex relationship between genetic variation and inflammation within the context of
Tsimane life history.
A unique aspect of our study pertained to examining the genetic association of single
nucleotide polymorphisms with blood CRP levels in an indigenous population living in a
highly infectious environment and with elevated levels of inflammation. It is possible that in
populations with a high inflammatory burden such as the Tsimane, the association of CRP
genotypes that predispose individuals to high basal levels of serum CRP may not be
detectable (Hage and Szalai 2007, 2009). By comparison, studies of the Bimoba of Ghana
have reported an association between cytokine levels and single nucleotide polymorphisms
in the IL-10 gene (Kuningas et al. 2009; May et al. 2009, 2010), although allele frequency
distributions were not evaluated as a function of age. Compared to other populations, the
indigenous peoples of the Amazonian basin may also harbor unique SNPs and/or lack
additional variants as a result of selective pressures from pathogens present in their
environment over time.
Future studies in this distinct population that utilize novel genetic/genomics methods, such
as genome-wide association studies (Collins et al. 1997; Goldstein 2009; Hardy and
Singleton 2009), will contribute to expanding our understanding of the links between
environmental factors, genes, selection, and traits relevant to human disease. These data are
being further examined in conjunction with a life-history analysis of physical, cognitive, and
social factors. In examining the influence of the environment on selective pressures and
human genetic diversity, we can begin to better understand and resolve the influence of
genetics and the environment on health and age-associated health outcomes.
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Figure 1.
Probability of survival (lx) by age in 1950–1989 and 1990–2000 among the Tsimane.
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Figure 2.
Serum C-reactive protein (CRP) levels are associated with apolipoprotein E (apoE) alleles.
*p < 0.05. Legend: Blood CRP (mg/dl serum) from all ages in association with apoE alleles.
No apoE2 was detected. Further statistical analysis is provided in Table 5.
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Table 1
Clinical characteristics of the Tsimane population
No. Mean (SD) or % Range
Age 917 35.8 (19.6) 5 – 90
Males (%) 917 49.2
Anthropometric measures
 Height (cm) 854 149.9 (28.7) 81.3 – 178.2
 Males 152.6 (17.9)
 Females 147.3 (35.8)
 Body mass index (BMI, kg/m2) 852 22.2 (4.0) 0.7 – 38.1
 Underweight (BMI <18.5) 19.8
 Overweight (BMI ≥ 25) 21.1
 Obese (BMI ≥ 30) 3.1
Markers of inflammation and infection
 C-reactive protein (CRP, mg/l) 635 7.4 (16.2) 0.15 – 150.0
 <3 (%) 58.9
 3.0–9.99 (%) 26.6
 ≥10.00 (%) 14.5
 Interleukin-6 (IL6, pg/ml) 292 5.3 (7.9) 2.0 – 57.4
 <2.68 (%) 40.4
 ≥2.68 (%) 59.6
White blood cell count 829 10344 4, 400 – 21, 500
Erythrocyte sedimentation rate 831 34.7 (19.9) 2 – 115
Note: The majority of the % underweight are children age ≤ 11.
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Table 2
Proinflammatory genotypes of apolipoprotein E (apoE), C-reactive protein (CRP), and interleukin-6 (IL-6)
based on previous studies
dbSNP Number Associated with Proinflammatory or At-risk Genotype (Reference)
Proinflammatory Genotype in
Tsimane?
rs429358/rs7412 apoE E4/E4 Yes, E3/E4 alleles present
rs405509 apoE GG (Bizarro et al. 2009) Yes, G/T alleles present
rs1205 CRP GG (Crawford et al. 2006; Eiriksdottir et al. 2009; Lange
et al. 2006; Teng et al. 2009)
Yes, G/A alleles present
rs1417938 CRP TT (Crawford et al. 2006; Lange et al. 2006) Yes, A/T alleles present
rs1800947 CRP GG (Crawford et al. 2006; Lange et al. 2006; Rizzello et
al. 2007; Teng et al. 2009)
Yes, only G allele present
rs3093061 CRP AA (Crawford et al. 2006) Yes, only A allele present
rs3093062 CRP GG (Szalai et al. 2005) Yes, only G allele present
rs2808630 CRP AA (Crawford et al. 2006) Yes A/G alleles present
rs3091244 CRP AA (Kathiresan et al 2006; Ridker et al. 2008; Teng et al.
2009)
Yes, A/C/T alleles present
rs1800795 IL-6 GG (Bamouldi et al. 2006; Walston et al. 2005) Yes, only G allele present
Biodemography Soc Biol. Author manuscript; available in PMC 2012 December 24.
$watermark-text
$watermark-text
$watermark-text
VASUNILASHORN et al. Page 19
Ta
bl
e 
3
Po
pu
la
tio
n-
ba
se
d 
al
le
le
 fr
eq
ue
nc
ie
s a
t C
-re
ac
tiv
e 
pr
ot
ei
n 
(C
RP
)-a
sso
cia
ted
 SN
Ps
: r
s1
41
79
38
, rs
18
00
94
7, 
rs3
09
30
61
, rs
30
93
06
2, 
rs3
09
12
44
, rs
12
05
, a
nd
rs
28
08
63
0;
 ap
ol
ip
op
ro
te
in
 E
 (a
po
E)
-as
so
cia
ted
 SN
P: 
rs4
05
50
9; 
int
erl
eu
kin
-6 
(IL
-6)
-as
so
cia
ted
 SN
P: 
rs1
80
07
95
Po
pu
la
tio
ns
A
fr
ic
an
A
sia
n
C
au
ca
sia
n
Ts
im
an
e
A
fr
ic
an
Y
or
ub
a
A
sia
n
H
an
 C
hi
ne
se
Ja
pa
ne
se
C
au
ca
sia
n
Eu
ro
pe
an
H
isp
an
ic
CR
P
rs
14
17
93
8
 
A
62
n
a
4
n
a
3
5
47
n
a
n
a
 
T
38
n
a
96
n
a
97
95
53
n
a
n
a
rs
18
00
94
7
 
C
0
n
a
0
n
a
7
3
9
n
a
n
a
 
G
10
0
n
a
10
0
n
a
93
97
91
n
a
n
a
rs
30
93
06
1
 
A
10
0
10
0
n
a
94
n
a
n
a
n
a
78
n
a
 
G
0
0
n
a
6
n
a
n
a
n
a
22
n
a
rs
30
93
06
2
 
A
0
6
n
a
n
a
0
0
0
n
a
6
 
G
10
0
94
n
a
n
a
10
0
10
0
10
0
n
a
94
rs
30
91
24
4
 
A
62
n
a
0
n
a
n
a
n
a
3
n
a
n
a
 
C
37
n
a
78
n
a
n
a
n
a
61
n
a
n
a
 
T
1
n
a
22
n
a
n
a
n
a
36
n
a
n
a
rs
12
05
 
A
32
14
15
55
56
73
31
25
33
 
G
68
86
85
45
44
27
69
75
66
rs
28
08
63
0
 
A
95
94
82
81
76
89
70
64
76
 
G
5
6
18
19
24
11
30
36
24
ap
oE
rs
40
55
09
 
G
24
n
a
76
n
a
34
27
n
a
50
n
a
Biodemography Soc Biol. Author manuscript; available in PMC 2012 December 24.
$watermark-text
$watermark-text
$watermark-text
VASUNILASHORN et al. Page 20
Po
pu
la
tio
ns
A
fr
ic
an
A
sia
n
C
au
ca
sia
n
Ts
im
an
e
A
fr
ic
an
Y
or
ub
a
A
sia
n
H
an
 C
hi
ne
se
Ja
pa
ne
se
C
au
ca
sia
n
Eu
ro
pe
an
H
isp
an
ic
 
T
76
n
a
24
n
a
66
73
n
a
50
n
a
IL
-6
rs
18
00
79
5
 
C
0
4
0
0
0
0
50
52
20
 
G
10
0
96
10
0
10
0
10
0
10
0
50
48
80
CE
U
 =
 U
ta
h 
re
sid
en
ts 
of
 N
or
th
er
n 
an
d 
W
es
te
rn
 E
ur
op
ea
n 
de
ce
nt
; Y
or
ub
a 
= 
Y
or
ub
a 
pe
op
le
 o
f N
ig
er
ia
; n
a 
= 
N
ot
 a
va
ila
bl
e.
Biodemography Soc Biol. Author manuscript; available in PMC 2012 December 24.
$watermark-text
$watermark-text
$watermark-text
VASUNILASHORN et al. Page 21
Ta
bl
e 
4
Fr
eq
ue
nc
y 
(%
) o
f a
po
lip
op
rot
ein
 E
 (a
po
E)
 an
d C
-re
ac
tiv
e p
rot
ein
 (C
RP
) p
oly
mo
rph
ism
s b
y a
ge
 gr
ou
p
A
ge
X
2
p-
v
a
lu
e
5–
9
10
–5
9
60
+
A
po
lip
op
ro
te
in
 E
ap
oE
 
E3
/E
3
74
.0
76
.0
68
.1
6.
13
0.
19
 
E3
/E
4
26
.0
21
.3
26
.9
 
E4
/E
4*
0.
0
2.
7
5.
0
rs
40
55
09
 
G
G
*
6.
1
6.
4
5.
9
3.
6
0.
46
 
G
T
22
.4
35
.0
36
.4
 
TT
71
.4
58
.6
57
.6
C-
re
ac
tiv
e 
pr
ot
ei
n
rs
14
17
93
8
 
A
A
42
.0
42
.6
30
.3
6.
62
0.
16
 
A
T
42
.0
40
.4
48
.7
 
TT
*
16
.0
17
.0
21
.0
rs
30
91
24
4
 
A
A
*
42
.0
42
.8
30
.3
16
.8
1
0.
03
 
A
C
42
.0
39
.6
46
.2
 
A
T
0.
0
0.
8
2.
5
 
CC
16
.0
16
.7
19
.3
 
CT
0.
0
0.
1
1.
7
rs
12
05
 
G
G
*
42
.9
50
.0
43
.3
4.
39
0.
36
 
A
G
49
.0
37
.5
42
.5
 
A
A
8.
1
12
.5
14
.2
rs
28
08
63
0
 
G
G
0.
0
0.
3
0.
0
5.
14
0.
27
 
A
G
6.
0
9.
4
15
.1
Biodemography Soc Biol. Author manuscript; available in PMC 2012 December 24.
$watermark-text
$watermark-text
$watermark-text
VASUNILASHORN et al. Page 22
A
ge
X
2
p-
v
a
lu
e
5–
9
10
–5
9
60
+
 
A
A
*
94
.0
90
.3
84
.9
*
Pr
oi
nf
la
m
m
at
or
y 
ge
no
ty
pe
 in
 so
m
e 
po
pu
la
tio
ns
 (U
.S.
 N
ati
on
al 
He
alt
h a
nd
 N
utr
itio
n E
xa
mi
na
tio
n S
urv
ey
, U
.S.
 Fr
am
ing
ha
m 
He
art
 St
ud
y, 
an
d a
 T
aiw
an
ese
 po
pu
lat
ion
).
Biodemography Soc Biol. Author manuscript; available in PMC 2012 December 24.
$watermark-text
$watermark-text
$watermark-text
VASUNILASHORN et al. Page 23
Table 5
Regression models predicting levels of log-transformed c-reactive protein (CRP) from genotypes of apoE and
CRP
Gene
Log CRP
Model I (N = 624) Model II (N = 578)
b p-value b p-value
apoE
 Age 0.004 <.01 0.003 <.01
 Male −0.042 0.32 −0.010 0.77
 Body mass index 0.010 0.11
 apoE4 presence −0.153 <.01 −0.154 <.01
apoE
 Age 0.004 <.01 0.003 <.01
 Male −0.049 0.26 −0.024 0.60
 Body mass index 0.011 0.11
 rs405509_GG 0.0218 0.82 −0.005 0.96
CRP
 Age 0.004 <.01 0.003 0.01
 Male −0.045 0.30 −0.019 0.68
 Body mass index 0.011 0.09
 rs1417938_TT −0.040 0.48 −0.023 0.70
CRP
 Age 0.004 <.01 0.003 <.01
 Male −0.044 0.31 −0.019 0.68
 Body mass index 0.011 0.10
 rs3091244_AA 0.056 0.21 0.039 0.40
CRP
 Age 0.004 <.01 0.003 0.01
 Male −0.050 0.25 −0.023 0.61
 Body mass index 0.012 0.07
 rs2808630_AA −0.055 0.44 −0.073 0.33
CRP
 Age 0.004 <.01 0.003 0.01
 Male −0.044 0.31 −0.022 0.64
 Body mass index 0.012 0.08
 rs1205_GG 0.091 0.04 0.074 0.11
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